Rossari Biotech Limited
NSE: ROSSARI · Specialty Chemicals
Snapshot
Unlock Rossari Biotech Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Rossari Biotech Limited is a specialty chemicals manufacturer providing diverse solutions for industries including textiles, soaps and detergents, water treatment, and animal health. The company operates through a broad portfolio that spans industrial performance chemicals, home and personal care products, and poultry nutrition.
Business Model
The company generates revenue through the development, manufacture, and sale of customised chemical formulations and specialty ingredients. It leverages its research and development capabilities to serve both domestic and international markets across multiple industrial verticals.
Growth Outlook
Growth is driven by the expansion of its sustainable chemical solutions and the diversification of its product portfolio into pet grooming and poultry nutrition. The company continues to focus on enhancing its market presence in both domestic and international specialty chemical segments.
Key Risks
- Raw Material Price Volatility. Fluctuations in the cost of petrochemical-based raw materials can significantly impact operating margins.
- Regulatory Compliance. The chemical industry is subject to stringent environmental and safety regulations that may necessitate continuous capital expenditure.
- Competitive Intensity. The company faces stiff competition from both domestic players and global chemical giants in the specialty chemicals space.
- Foreign Exchange Risk. As an exporter, the company is exposed to currency fluctuations that may affect the profitability of international operations.
Start your research today
Unlock AI insights, financials, peers and live data on Rossari Biotech Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹2,550 Cr
TTM · consolidated
NET PROFIT
₹151 Cr
TTM · consolidated
EPS
₹27.25
TTM · consolidated
RETURN ON EQUITY
12.0%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
16.5%
TTM · consolidated
P/E
16.9x
Q1 FY27 · consolidated
EV/EBITDA
8.9x
Q1 FY27 · consolidated
EBITDA MARGIN
12.7%
TTM · consolidated
NET PROFIT MARGIN
5.0%
Q1 FY27 · consolidated
DEBT TO EQUITY
0.3x
Q1 FY27 · consolidated
Peers · Specialty Chemicals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Rossari Biotech LimitedROSSARI | ₹2,549 Cr | 16.89 | 8.92 | 19.5% | 12.7% | 12.0% | 16.5% | -26.7% |
NOCIL LimitedNOCIL | ₹2,880 Cr | 43.55 | 18.79 | 1.0% | 11.1% | 3.7% | 4.8% | -6.8% |
Ddev Plastiks Industries Ltd.DDEVPLSTIK | ₹2,825 Cr | 13.24 | 8.29 | 15.3% | 10.8% | 23.1% | 33.8% | -15.4% |
S H Kelkar & Co.SHK | ₹2,088 Cr | 23.46 | 10.77 | 9.7% | 10.9% | 6.8% | 12.3% | -43.4% |
Camlin Fine Sciences LimitedCAMLINFINE | ₹1,981 Cr | 381.96 | 21.41 | 8.4% | 6.4% | 0.1% | 0.5% | -51.1% |
PaushakPAUSHAKLTD | ₹1,937 Cr | 10.54 | 27.62 | 3.6% | 33.3% | 8.3% | 9.5% | -87.1% |
As of Q1 FY27
Financials
Rossari Biotech Limited
NSE: ROSSARI · Specialty Chemicals
Snapshot
Unlock Rossari Biotech Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Rossari Biotech Limited is a specialty chemicals manufacturer providing diverse solutions for industries including textiles, soaps and detergents, water treatment, and animal health. The company operates through a broad portfolio that spans industrial performance chemicals, home and personal care products, and poultry nutrition.
Business Model
The company generates revenue through the development, manufacture, and sale of customised chemical formulations and specialty ingredients. It leverages its research and development capabilities to serve both domestic and international markets across multiple industrial verticals.
Growth Outlook
Growth is driven by the expansion of its sustainable chemical solutions and the diversification of its product portfolio into pet grooming and poultry nutrition. The company continues to focus on enhancing its market presence in both domestic and international specialty chemical segments.
Key Risks
- Raw Material Price Volatility. Fluctuations in the cost of petrochemical-based raw materials can significantly impact operating margins.
- Regulatory Compliance. The chemical industry is subject to stringent environmental and safety regulations that may necessitate continuous capital expenditure.
- Competitive Intensity. The company faces stiff competition from both domestic players and global chemical giants in the specialty chemicals space.
- Foreign Exchange Risk. As an exporter, the company is exposed to currency fluctuations that may affect the profitability of international operations.
Start your research today
Unlock AI insights, financials, peers and live data on Rossari Biotech Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹2,550 Cr
TTM · consolidated
NET PROFIT
₹151 Cr
TTM · consolidated
EPS
₹27.25
TTM · consolidated
RETURN ON EQUITY
12.0%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
16.5%
TTM · consolidated
P/E
16.9x
Q1 FY27 · consolidated
EV/EBITDA
8.9x
Q1 FY27 · consolidated
EBITDA MARGIN
12.7%
TTM · consolidated
NET PROFIT MARGIN
5.0%
Q1 FY27 · consolidated
DEBT TO EQUITY
0.3x
Q1 FY27 · consolidated
Peers · Specialty Chemicals
As of Q1 FY27